/H
ϩ exchanger phosphorylation was blocked by the MAP kinase kinase inhibitor U-0126 (5 M). These results demonstrate that H 2O2-induced activation of MAP kinases may contribute to cardiac myocyte dysfunction during ischemia-reperfusion. reactive oxygen species; extracellular signal-regulated kinase; c-Jun NH2-terminal kinase; p38 mitogen-activated protein kinase REPERFUSION OF AN ISCHEMIC myocardium leads to a burst in the production of reactive oxygen species (ROS) that is associated with contractile dysfunction, Ca 2ϩ overload, and myocardial stunning (15) . Ischemia-reperfusion injury also initiates activation of several signaling cascades, including mitogen-activated protein (MAP) kinases and tyrosine kinases such as Src (1, 7, 31, 38) . However, the exact contribution of ROS to the activation of these signaling events remains unknown.
MAP kinases regulate a number of cellular events that are altered during the reperfusion of an ischemic myocardium, including phosphorylation of heat shock proteins 20 and 27 (13) , regulation of apoptotic signaling cascades (see Ref. 37 for a recent review), enhanced gene expression (8) , and phosphorylation of the Na ϩ /H ϩ exchanger (NHE) to increase its activity (39) . Activation of NHE is responsible for the postischemic restoration of intracellular pH (pH i ). The increased Na ϩ influx that arises from NHE activation leads to a secondary increase in intracellular Ca 2ϩ levels via an indirect inhibition of Na ϩ /Ca 2ϩ exchange (12, 19, 40) . Three subfamilies of MAP kinases have been clearly identified in the heart: the extracellular signal-regulated kinases (ERK1/2), the c-Jun NH 2 -terminal kinases (JNKs), and the p38 MAP kinases. We and others have investigated the ability of ROS to regulate MAP kinase signaling in primary cultured neonatal cardiac myocytes (3, 31) . Physiological concentrations of H 2 O 2 (5-100 M) activated NHE1 in an ERK1/2-dependent manner in cultured neonatal cardiac myocytes (31) . However, extrapolation of these results to adult cells is difficult, because there are marked phenotypic differences between neonatal and adult cardiac myocytes, including age-dependent changes in protein kinase C (PKC) expression (30) , tyrosine kinase-dependent inhibition of L-type Ca 2ϩ channels (20) , and ␤-adrenergic receptor signaling (23) . In addition, alterations in ERK signaling between neonatal and adult cardiac myocytes in response to angiotensin II have been reported (11, 32) . Therefore, identification of the cellular signaling events involved in H 2 O 2 -induced MAP kinase activation in primary cultured adult rat ventricular myocytes (ARVM) is important for an understanding of in vivo changes in cardiac function during the ischemia-reperfusion injury.
Although several studies have demonstrated the effects of high doses of H 2 O 2 on adult cardiac myocyte function (17, 18) , little is known about the effect of low, physiological concentrations of H 2 O 2 on intracellular signal transduction. The present study demonstrates a significant decrease in ARVM contractility by low doses of H 2 O 2 . Exposure of primary culture of ARVM to these low doses of H 2 O 2 activates ERK1/2, p38 MAP kinase, and JNK members of the MAP kinase superfamily. Of these three MAP kinases, the ERK1/2 pathway mediated H 2 O 2 -induced phosphorylation of NHE1.
METHODS
Isolation of ARVM. ARVM were isolated from male Sprague-Dawley rats (250-350 g) by cardiac retrograde aortic perfusion, as previously described (35) , with minor modifications. Briefly, rats were anesthetized with pentobarbital sodium (50 mg/kg ip). The hearts were rapidly dissected and perfused with Krebs buffer (mM: 118 NaCl, 4.7 KCl, 25 NaHCO 3, 1.8 CaCl2, 1.2 Mg2SO4, 1.2 KH2PO4, and 11 glucose), Ca 2ϩ -free Krebs buffer, and Ca 2ϩ -free Krebs buffer containing 100 U/ml type II collagenase (Worthington). Ventricular tissue was minced and further digested in collagenase-BSA Krebs buffer containing 25 M CaCl2. The resulting cells were resuspended in perfusion buffer with 3% BSA, in which the concentration of CaCl2 was increased in a stepwise manner to 1 mM. Cells were resuspended in medium 199 (M199) supplemented with 5 mM creatine, 2 mM L-carnitine, and 5 mM taurine and then plated on laminincoated dishes at a density of 4 ϫ 10 5 /100 mm. After 1 h, the medium was changed to remove loosely attached cells. Rodshaped myocytes (Ͼ90%) were cultured for an additional 1 h before the start of the experiments.
Preparation of cell lysates for MAP kinase experiments. ARVM were incubated at 37°C in M199 containing H 2O2, inhibitors, or vehicle for various times, lysed in ice-cold buffer containing 50 mM NaCl, 50 mM NaF, 50 mM sodium pyrophosphate, 5 mM EDTA, 5 mM EGTA, 2 mM Na3VO4, 0.5 mM phenylmethylsulfonyl fluoride, 10 mM HEPES, pH 7.4, 0.1% Triton X-100, and 10 g/ml leupeptin, and immediately frozen on ethanol-dry ice. Cell lysates were then thawed on ice, scraped, sonicated, and centrifuged at 10,000 g at 4°C for 30 min. Supernatants were used immediately or stored at Ϫ80°C. Protein concentrations were determined using a bicinchoninic acid protein assay (Pierce) according to the manufacturer's protocol.
Western blot analysis. Western blot analysis was performed as described elsewhere (31) . Cell lysates (35 g) were separated by 10% SDS-PAGE and transferred to nitrocellulose membranes. The primary antibodies were anti-total ERK1 and ERK2 antibodies (1:5,000; Santa Cruz), antiactive ERK1/2 (1:3,000; Promega), anti-total p38 (1:1,000; New England Biolabs), and anti-phospho-p38 MAP kinase (1:2,000; New England Biolabs). Immunoreactive bands were visualized using enhanced chemiluminescence (Amersham). Autoradiograms exposed in the linear range of film density were scanned, and densitometric analysis was performed with NIH Image software.
JNK immune complex kinase assays. ARVM were lysed by the addition of RIPA buffer (150 mM NaCl, 1.5 mM MgCl 2, 10 mM NaF, 10 mM sodium pyrophosphate, 1 mM EGTA, 0.1 mM Na3VO4, 24 mM sodium deoxycholate, and 25 mM HEPES, pH 7.4, 1% Triton X-100, 0.1% SDS, and 10% glycerol). Cell lysates containing 600 g of protein were incubated with 4 g of anti-JNK1/SAPK antibody (UBI) overnight at 4°C. Lysates were then incubated with 40 l of protein A-agarose beads for 90 min at 4°C, and the beads were collected by centrifugation. The beads were washed once with 500 l of RIPA buffer, once with 500 l of wash buffer A (0.5 mM LiCl and 20 mM Tris), once with wash buffer B (1 mM EDTA and 20 mM Tris), and once with kinase buffer (10 mM MnCl 2, 1 mM dithiothreitol, and 20 mM Tris). Immunoprecipitates were resuspended in 10 l of kinase buffer supplemented with 5 M ATP, 5 mM MgCl2, 10 Ci of [␥-32 P]ATP, and 4 g of glutathione S-transferase (GST)-cJun-(1-79) (Calbiochem). After incubation for 20 min at 20°C, the reaction was terminated by adding Laemmli sample buffer and heating at 100°C for 10 min. c-Jun was resolved by SDS-PAGE. Incorporation of 32 P into GST-c-Jun-(1-79) was determined by densitometric analysis of the c-Jun band identified by autoradiography.
In-gel kinase assays. NHE1 kinase activity and MAP kinase activity were analyzed by the in-gel kinase assay as described previously (31) . Cell lysates (35 g) were fractionated by SDS-PAGE in a gel in which 0.15 mg/ml of NHE1 fusion protein (amino acids 501-815 of NHE1 coupled to GST) or 0.1 mg/ml of myelin basic protein (MBP) had been copolymerized. The phosphorylation assay was performed by placing the gel in 10 ml of buffer containing 50 M ATP with 100 Ci of [␥-
32 P]ATP and incubating it for 1 h at 30°C. The reaction was terminated by immersing the gel in fixative solution (5% trichloroacetic acid and 10 mM sodium pyrophosphate). The radioactivity was quantified by densitometric analysis of scanned images.
Measurement of single-cell contractility. Myocytes were cultured for 1-2 h in M199 on laminin-coated glass coverslips. The coverslip was placed in a perfusion chamber with internal stimulating platinum electrodes (Warner) and imaged using an inverted microscope (model IX50, Olympus) and charge-coupled device camera (Philips). Rod-shaped cells with no blebbing or spontaneous contractions were chosen for imaging. The chamber was perfused with Tyrode's basic salt solution for 2 min, and cells were paced at 2 Hz (3-ms duration). This equilibration period was followed by a 10-min perfusion with 50 M H 2O2 in Tyrode's basic salt solution and a 10-min washout period with continued stimulation throughout the experiment. Cell contractility was recorded with a video edge detection system (Crescent Electronics) and analyzed using the Digi-Med System Integrator (model 2001) and the Cell Length Analysis program (MicroMed). The average resting cell length was 123 Ϯ 6 m (n ϭ 11). Percent contraction was defined as the change in cell length divided by the resting length and averaged 9.7 Ϯ 0.4% in control cells at 2 Hz. Changes in contractile amplitude were expressed relative to the percent contraction of control cells (set at 100%).
Data analysis. Data were analyzed using InStat statistical software (Graphpad). Values are means Ϯ SE. One-way analysis of variance with a Dunnett's post test was used to compare control with treated groups. Differences between groups were considered statistically significant at P Ͻ 0.05.
RESULTS

Low concentration of H 2 O 2 elicited a significant decrease in ARVM contractility.
A video edge detection system was used to monitor the effects of H 2 O 2 on single ARVM contractility (Fig. 1 ). ARVM were paced at 2 Hz for a 2-min equilibration period. Exposure to 50 M H 2 O 2 for 10 min induced a significant, 35% decrease in the contraction amplitude of ARVM compared with control. This contractile impairment was sustained throughout the 10-min washout period. (Fig. 2A, middle blot) . ERK1/2 activation was confirmed using in-gel kinase assays with MBP as a substrate. Compared with control, treatment with H 2 O 2 (5-200 M) resulted in a concentration-dependent increase in MBP phosphorylation by 42-and 44-kDa kinases, the molecular weights of ERK2 and ERK1, respectively ( Fig. 2A,  bottom blot) . Thus both measures of ERK1/2 MAP kinase activation yielded similar results.
A similar concentration-dependent activation of p38 MAP kinases and JNK by H 2 O 2 was observed (Fig. 2, B  and C 3, A and B) . Activation of both MAP kinases was detected at 5 min and was maximal at 20 min (6.2 Ϯ 1.2-fold vs. control for ERK1/2 and 6.3 Ϯ 0.9-fold vs. control for p38) but returned to values close to baseline at 60 min. In contrast, significant JNK activation, as assessed by immune complex kinase assays, occurred much more slowly but was prolonged (Fig. 3C) . Significant JNK activation by 50 M H 2 O 2 did not occur until 60 min (1.7 Ϯ 0.2-fold vs. control) and was sustained at 3.5 h (1.8 Ϯ 0.2-fold vs. control).
To determine that H 2 O 2 was the oxidant responsible for activation of MAP kinases, the ability of the H 2 O 2 scavenger catalase to block the effect of H 2 O 2 was studied. Pretreatment with catalase (400 U/ml) for 10 min completely abolished the activation of all three MAP kinases by 50 M H 2 O 2 (Fig. 4) . In contrast, pretreatment with the superoxide scavenger superoxide dismutase (1,000 U/ml) for 30 min failed to inhibit MAP kinase activation by H 2 O 2 (Fig. 4) .
To mimic the free radical burst that occurs during ischemia-reperfusion injury, we tested the effect of a brief exposure of ARVM to H 2 O 2 . ARVM were treated with 50 M H 2 O 2 for 5 min. The medium was then replaced with M199, and ARVM were incubated for an additional 5, 15, and 55 min (205 min for JNK activation) in the absence of H 2 O 2 . Brief exposure to H 2 O 2 was sufficient to cause a transient activation of ERK1/2 and p38 MAP kinase and a sustained activation of JNK (Fig. 5) that persisted after the removal of H 2 O 2 . 
Role of tyrosine kinases and PKC in H 2 O 2 -induced MAP kinase activation.
To determine whether one or more upstream tyrosine kinases were involved in the H 2 O 2 -induced MAP kinase activation in ARVM, cells were pretreated with the tyrosine kinase inhibitor genistein (100 M) or the selective Src family tyrosine kinase inhibitor PP-2 (10 M) for 45 min. Neither genistein nor PP-2 had an effect on the phosphorylation of ERK1/2 and p38 MAP kinase by 50 M H 2 O 2 (Fig. 6, A and B) . In contrast, genistein and PP-2 caused a 40 and 70% inhibition of H 2 O 2 -induced JNK activation, respectively (Fig. 6C) . We next examined whether PKC was involved in the H 2 O 2 -induced MAP kinase activation in ARVM. Pretreatment with the PKC inhibitor chelerythrine (5 M, 45 min) caused a partial inhibition of H 2 O 2 -induced activation of ERK1/2 (50%) and p38 MAP kinase (45%) and a complete inhibition of JNK activation (Fig. 6) .
ERK1/2-dependent NHE1 phosphorylation by H 2 O 2 . We previously showed that low doses of H 2 O 2 cause a rapid, ERK1/2-dependent activation of NHE1 (31) . The primary sequence of NHE1 contains several sites that are suitable phosphorylation sites for proline-directed MAP kinases (12) . Because NHE1 activity is regulated by phosphorylation, we determined whether H 2 O 2 -induced MAP kinase activation mediates NHE1 phosphorylation in ARVM. In-gel kinase assays using a recombinant NHE1-GST fusion protein as a substrate were performed. H 2 O 2 induced a concentration-dependent increase in NHE1 phosphorylation by two proteins that corresponded to ERK1 (44 kDa) and ERK2 (42 kDa; Fig. 7A ). The time course of H 2 O 2 -induced MAP kinase-dependent NHE activation was nearly identical to that of H 2 O 2 -induced ERK1/2 phosphorylation (compare Fig. 7B with Fig. 3A) . To confirm that the ERK pathway is a critical step in H 2 O 2 -mediated stimulation of NHE1, the effects of the specific MAP kinase kinase (MEK) inhibitor U-0126 and the p38 MAP kinase inhibitor SB-203580 were studied. Pretreatment with U-0126 (5 M, 45 min) completely abolished the ERK1/2-dependent phosphorylation of NHE1 induced by 50 M H 2 O 2 , whereas pretreatment with SB-203580 (10 M, 45 min) had no effect (Fig. 7C) . U-0126 completely inhibited H 2 O 2 -induced ERK1/2 activation (data not shown).
DISCUSSION
The most important findings of the present study are that low physiological concentrations of H 2 O 2 result in activation of multiple MAP kinases in adult ventricular myocytes that are associated with altered contractile function and NHE phosphorylation. The H 2 O 2 concentrations (5-100 M) are similar to those observed during a burst in free radical production that occurs on reperfusion of an ischemic myocardium (15). However, Ն200 M H 2 O 2 actually decreased MAP kinase activity, suggesting that these higher concentrations may exert cytotoxic effects. H 2 O 2 induced a rapid but transient phosphorylation in ERK1/2 and p38 MAP kinase in ARVM but a slower, more sustained JNK activation. These MAP kinase activations required only a brief exposure to H 2 O 2 .
The physiological roles of MAP kinase activation during ischemia-reperfusion injury in the intact myocardium are somewhat controversial. For example, ischemia-reperfusion elicited an increase in ERK1/2 activation in conscious rabbits (27) , isolated guinea pig hearts (39) , and isolated rat hearts (21) . In contrast, Bogoyevitch et al. (6) reported that 10-20 min of ischemia with or without reperfusion failed to activate ERK1/2. However, Ping et al. (27) examined MAP kinase activity in the nuclear and cytosolic fractions of heart tissue and found a significant elevation of ERK1/2 only in the nuclear compartment. On the other hand, other groups determined MAP kinase activity only on the cytosolic fraction (6, 7, 21, 39) , and in the study by Bogoyevitch et al., ERK activity was measured in the cytosolic fraction after fast protein liquid chromatography on Mono Q. Thus the conflicting re- sults may be attributed to species-related differences or variation in the preparation of myocardium samples. In contrast, our results provide direct evidence that ROS directly activate ERK1/2 MAP kinases in cardiac myocytes.
Our results also demonstrate that low concentrations of H 2 O 2 induced a rapid but transient activation of p38 MAP kinase and a slower, sustained activation of JNK in ARVM. These data are in agreement with previous studies by Ping et al. (28) , who reported a sustained activation of JNK, but only a transient activation of p38 MAP kinase, triggered by ischemic preconditioning in the hearts of conscious rabbits. Schneider et al. (34) also reported a transient activation of p38 MAP kinase, whereas Bogoyevitch et al. (6) reported a sustained activation of p38 MAP kinase in isolated rat hearts. Besides the differences in sample preparation for MAP kinase activity assays, these differences may also reflect discrepancies between animal models or ischemic protocols. Our study is the first to demonstrate, on the cellular level, that H 2 O 2 induces a rapid but transient activation of p38 in ARVM.
The activation of MAP kinase by ROS, which contribute to cardiac myocyte dysfunction, appears at first glance to be in contradiction to the well-documented MAP kinase activation by growth factors and neurohormones. However, recent studies suggested the importance of the ERK1/2 pathway for myocyte survival in ischemic myocardium on the basis of the results that pretreatment with the MEK1 inhibitor PD-98059 reduced the number of apoptotic cells on isolated rat hearts subjected to global ischemia (44) and H 2 O 2 -treated rat neonatal myocytes (2, 3). Our results do not exclude the possibility of protective roles of MAP kinase activation in ischemic myocardium. For example, it is possible that MAP kinases could regulate the expression and activation of heat shock proteins or the expression of genes that would prevent further myocardial damage (8, 13) . It is also possible that differences in the magnitude and duration of MAP kinase activation can result in different physiological responses. For example, transient activation of p38 and JNK by tumor necrosis factor-␣ is a survival signal, whereas persistent activation induces apoptosis (16, 29) . Transient ERK1/2 activation leads to proliferation, whereas sustained activation mediates growth arrest (4, 5) . In addition, the simultaneous activations of multiple MAP kinases may result in different responses due to cross talk. Kusuhara et al. (22) showed that activation of p38 MAP kinase leads to decreased ERK1/2 signaling due to inhibition of MEK activity. Therefore, it is tempting to speculate that different stimuli, such as H 2 O 2 and phenylephrine, may elicit distinct functional responses by eliciting a specific temporal or spatial pattern of activation of a single MAP kinase pathway or by stimulating cross talk between multiple signaling pathways.
The activation of all three MAP kinases by H 2 O 2 in ARVM was PKC dependent (Fig. 6 ). This is consistent with the finding that PKC activates MAP kinases in neonatal myocytes (24, 31, 41) , isolated rat hearts (6, 14) , and in vivo rabbit hearts (28) . Activation of ERK1/2 and p38 by H 2 O 2 in ARVM was not tyrosine kinase dependent (Fig. 6) . In contrast, the tyrosine kinase inhibitor genistein and the Src inhibitor PP-2 partially inhibited the activation of JNK by H 2 O 2 . This is consistent with a study in adult rat myocytes that ␣-adrenoceptor stimulation of ERK1/2 was PKC dependent, but not genistein sensitive (33) . Yoshizumi et al. (43) reported an Src-and Cas-mediated activation of JNK, but not ERK1/2 and p38 MAP, kinase by H 2 O 2 in smooth muscle cells and also showed that JNK activation by H 2 O 2 was completely blocked in cells derived from src-deficient transgenic mice. Our data suggest a possible mechanism whereby tyrosine kinases are located upstream of JNK activation in response to H 2 O 2 , but not upstream of ERK1/2 and p38 MAP kinase activation. We previously showed that the activation of ERK1/2 by H 2 O 2 is partly modulated by the activity of upstream tyrosine kinases and PKC (31) in neonatal rat ventricular myocytes. Thus a role for tyrosine kinases in H 2 O 2 -induced MAP kinase activation appears to exhibit age-related differences in cardiac myocytes. Interestingly, Katsube et al. (20) reported that inhibition of basal L-type Ca 2ϩ channel currents by genistein in rat ventricular myocytes was greater in neonatal than in adult cells, suggesting the existence of agerelated changes in the expression of tyrosine kinases or in their coupling to channel regulation.
Many studies have established a good correlation between myocardial stunning, ROS, and Ca 2ϩ overload with ischemia-reperfusion injury. Early studies described a reversible depression of contractility during moderate ischemia-reperfusion, which was thought to be "cardioprotective," since it would serve to maintain myocardial integrity and viability during persistent ischemia (9) . Changes in ATP concentration, pH i , or Ca 2ϩ handling have been proposed as mechanisms responsible for acute, ischemic contractile dysfunction (15) . The data from our study suggest that ROS may contribute to ischemia-reperfusion injury through an ERK1/2-dependent NHE1 phosphorylation (Fig. 7) . The ability of the MEK inhibitor U-0126, but not the p38 inhibitor SB-203580, to abolish the H 2 O 2 -induced increase in NHE1 phosphorylation provides evidence that the ERK1/2, but not the p38, pathway is critical for H 2 O 2 -mediated stimulation of NHE1 in ARVM.
There is a large body of evidence to suggest that NHE1 activation during cardiac ischemia-reperfusion plays a major role in restoring pH i after an acid load. Phosphorylation of the exchanger is thought to be the primary mechanism responsible for increased NHE activity during ischemia-reperfusion injury (10). How- ever, the increases in intracellular Na ϩ concentration resulting from enhanced exchanger activity can result in Ca 2ϩ overload via the Na ϩ /Ca 2ϩ exchanger and actually exacerbate the damage to the myocardium (19) . Moreover, Myers et al. (26) reported that the NHE inhibitor cariporide prevented H 2 O 2 -induced impairment of postischemic ventricular function. ERK1/2 (and the downstream kinase p90 rsk ) regulate NHE activity by phosphorylation in the rat myocardium and in endothelin-stimulated rat neonatal ventricular myocytes (25) . Snabaitis et al. (36) demonstrated a similar requirement for ERK1/2, but not p38, in an ␣ 1 -adrenoreceptor-mediated NHE activation in ARVM. On the other hand, Kusuhara et al. (22) reported that ERK1/2 and p38 phosphorylate NHE1 in response to angiotensin II in vascular smooth muscle, although p38-mediated phosphorylation was associated with decreased NHE activity. The underlying cellular basis for these discrepancies remains unclear but may be in part due to the differences in agonists used to stimulate NHE1 phosphorylation or in cell type-specific regulatory mechanisms.
In conclusion, the present study is the first to characterize, at the cellular level, the activation of multiple MAP kinases in adult cardiac myocytes by ROS at physiologically relevant concentrations. It is possible that the ROS-and ERK1/2-dependent NHE1 activation may contribute to the contractile dysfunction observed during reperfusion injury. Future studies with antisense or dominant-negative strategies are needed to elucidate the exact pathophysiological roles of each kinase using models of oxidant-induced myocardial injury.
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